Hojat Dehghanbanadaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hojat Dehghanbanadaki has a total of 207 co-authors. Here are the top co-authors by number of shared publications:
- Yousef Moradi
Health Metrics and Evaluation Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences
9 shared publications Hossein Aazami
Tehran University of Medical Sciences, Tehran, Iran
7 shared publications- Hossein Aazami
Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
6 shared publications - Ghobad Moradi
Social Determinants of Health Research Center, Research Institute for Health Development Kurdistan University of Medical Sciences Sanandaj Iran
5 shared publications - James Morris Hotaling
Division of Urology, Department of Surgery, University of Utah Health, Salt Lake City, Utah, USA
4 shared publications Joemy M. Ramsay
Division of Urology, Department of Surgery, University of Utah Health, Salt Lake City, Utah, USA
4 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
A systematic review and meta-analysis of worldwide prevalence of HIV in men who have sex with men
Introduction: This systematic review and meta-analysis aimed to estimate the worldwide prevalence of human immunodeficiency virus (HIV) in men who have sex with men (MSM). Material and methods: Search was conducted in international databases (PubMed, Scopus, Web of Science, Embase, Ovid,...
- 25 September 2026
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
Open AccessA systematic review and meta-analysis of worldwide prevalence of HIV in men who have sex with men
Introduction: This systematic review and meta-analysis aimed to estimate the worldwide prevalence of human immunodeficiency virus (HIV) in men who have sex with men (MSM). Material and methods: Search was conducted in international databases (PubMed, Scopus, Web of Science, Embase, Ovid,...
- 20 May 2026
- Published by Springer Nature in International Journal Of Impotence Research
Impact of HCV infection on male reproductive hormones; a systematic review and meta-analysis
Previous research has suggested a correlation between hepatitis C infection and male reproductive hormones. This study systematically reviewed the literature and determined the pooled effect of hepatitis C infection on male reproductive hormones. PubMed, Scopus, and Web of Science were searched on 1 October 2024. Studies were included if they compared reproductive hormone levels between hepatitis C-positive and hepatitis C-negative men. Excluded were animal studies, reviews, editorials, preprints, and studies lacking hormone data or hepatitis C status differentiation. The effect measures were weighted mean differences. Heterogeneity was measured with I2 index. Risk of bias was assessed using the Newcastle-Ottawa Scale, and evidence certainty was evaluated with the GRADE approach. PROSPERO Registration number=CRD42024596571. The initial search yielded 569 documents. After screening, 10 documents were eligible for meta-analysis, each showing high methodological quality (NOS score≥7). Hepatitis C infection was associated with a decrease of 22.62 pmol/L free testosterone (95%CI: -28.65, -16.60; p-value < 0.01; I2 = 21.96%), an increase of 1.98 ng/ml prolactin (95%CI: 0.76, 3.19; p-value < 0.01; I2 = 75.28%), and an elevation of 37.66 nmol/L sex hormone binding globulin (95%CI: 21.81, 53.51; p-value < 0.01; I2 = 95.42%). No publication bias was detected for free testosterone, prolactin, or sex hormone binding globulin, whereas publication bias was observed for total testosterone and estradiol. After publication bias adjustment, hepatitis C infection was associated with 4.16 nmol/L lower total testosterone (95%CI: -4.74, -3.57) and 7.06 pg/ml higher estradiol (95%CI: 6.11, 8.02). Subgroup analysis showed stronger hepatitis C infection effects on free testosterone, prolactin, and estradiol in studies with an average participant age under 40 than in those over 40. In conclusion, hepatitis C infection has been associated with alterations in male reproductive hormones; however, as the certainty of evidence is low to very low (GRADE), these findings should be interpreted cautiously and require confirmation in well-designed studies before clinical implications can be established.
- 20 May 2026
- Published by Springer Nature in International Journal Of Impotence Research
Impact of HCV infection on male reproductive hormones; a systematic review and meta-analysis
Previous research has suggested a correlation between hepatitis C infection and male reproductive hormones. This study systematically reviewed the literature and determined the pooled effect of hepatitis C infection on male reproductive hormones. PubMed, Scopus, and Web of Science were searched on 1 October 2024. Studies were included if they compared reproductive hormone levels between hepatitis C-positive and hepatitis C-negative men. Excluded were animal studies, reviews, editorials, preprints, and studies lacking hormone data or hepatitis C status differentiation. The effect measures were weighted mean differences. Heterogeneity was measured with I2 index. Risk of bias was assessed using the Newcastle-Ottawa Scale, and evidence certainty was evaluated with the GRADE approach. PROSPERO Registration number=CRD42024596571. The initial search yielded 569 documents. After screening, 10 documents were eligible for meta-analysis, each showing high methodological quality (NOS score≥7). Hepatitis C infection was associated with a decrease of 22.62 pmol/L free testosterone (95%CI: -28.65, -16.60; p-value < 0.01; I2 = 21.96%), an increase of 1.98 ng/ml prolactin (95%CI: 0.76, 3.19; p-value < 0.01; I2 = 75.28%), and an elevation of 37.66 nmol/L sex hormone binding globulin (95%CI: 21.81, 53.51; p-value < 0.01; I2 = 95.42%). No publication bias was detected for free testosterone, prolactin, or sex hormone binding globulin, whereas publication bias was observed for total testosterone and estradiol. After publication bias adjustment, hepatitis C infection was associated with 4.16 nmol/L lower total testosterone (95%CI: -4.74, -3.57) and 7.06 pg/ml higher estradiol (95%CI: 6.11, 8.02). Subgroup analysis showed stronger hepatitis C infection effects on free testosterone, prolactin, and estradiol in studies with an average participant age under 40 than in those over 40. In conclusion, hepatitis C infection has been associated with alterations in male reproductive hormones; however, as the certainty of evidence is low to very low (GRADE), these findings should be interpreted cautiously and require confirmation in well-designed studies before clinical implications can be established.
- Open Access
- 6 March 2026
- Published by Springer Nature in Cardiovascular Diabetology – Endocrinology Reports
- Vol. 12 (1) , 10
A bibliometric analysis of systematic reviews and meta-analyses on diabetes mellitus: global research trends from scopus database (1988–2024)
Diabetes mellitus, a global epidemic, necessitates robust evidence synthesis to guide clinical practice. This study analyzes systematic reviews and meta-an
- 6 March 2026
- Published by Springer Nature in Cardiovascular Diabetology – Endocrinology Reports
- Vol. 12 (1) , 10
Open AccessA bibliometric analysis of systematic reviews and meta-analyses on diabetes mellitus: global research trends from scopus database (1988–2024)
Diabetes mellitus, a global epidemic, necessitates robust evidence synthesis to guide clinical practice. This study analyzes systematic reviews and meta-an
Seasonal Variations in Human Semen Parameters: A Systematic Review and Meta‐Analysis
Background: Male fertility can be influenced by environmental factors, including seasonal variation, which may cause fluctuations in semen quality. However, studies to date have reported inconsistent findings, limiting our understanding of how seasonality affects reproductive potential. A clearer picture of these patterns is essential for optimizing the timing and interpretation of fertility evaluations. Objective: To systematically review and meta‐analyze existing data on seasonal differences in semen analysis parameters. Materials and Methods: We searched PubMed, Web of Science, and Scopus up to March 18, 2025 using the key search terms of “semen parameter” and “seasonality,” along with their related terms. Initial search yielded 641 studies. The inclusion criteria were original articles or conference abstracts that investigated any human semen parameters across different seasons. After screening, 21 studies were included for meta‐analysis. We calculated the pooled weighted mean differences in semen parameters across different seasons using the random‐effects models. Results: Meta‐analyses of 21 studies with high methodological quality showed that winter and spring had better semen quality than summer and fall, in that they had higher sperm concentration of 3.24–6.07 million/mL, higher total sperm count of 14.63–19.74 million, and lower slow motility of 5.17%–11.75%. Additionally, winter had greater normal morphology of 1.30% than both fall and summer. Spring also had greater total motile sperm count of 4.34–4.38 million compared with fall and summer and greater normal morphology of 0.88% than summer. Summer had lower slow motility of 5.05% than fall. Conclusion: This meta‐analysis showed seasonal variations in semen parameters, with generally better semen quality in winter and spring compared with summer and fall. Specifically, these seasons were associated with higher sperm concentration, greater total sperm count, and reduced slow motility compared with summer and fall.
Seasonal Variations in Human Semen Parameters: A Systematic Review and Meta‐Analysis
Background: Male fertility can be influenced by environmental factors, including seasonal variation, which may cause fluctuations in semen quality. However, studies to date have reported inconsistent findings, limiting our understanding of how seasonality affects reproductive potential. A clearer picture of these patterns is essential for optimizing the timing and interpretation of fertility evaluations. Objective: To systematically review and meta‐analyze existing data on seasonal differences in semen analysis parameters. Materials and Methods: We searched PubMed, Web of Science, and Scopus up to March 18, 2025 using the key search terms of “semen parameter” and “seasonality,” along with their related terms. Initial search yielded 641 studies. The inclusion criteria were original articles or conference abstracts that investigated any human semen parameters across different seasons. After screening, 21 studies were included for meta‐analysis. We calculated the pooled weighted mean differences in semen parameters across different seasons using the random‐effects models. Results: Meta‐analyses of 21 studies with high methodological quality showed that winter and spring had better semen quality than summer and fall, in that they had higher sperm concentration of 3.24–6.07 million/mL, higher total sperm count of 14.63–19.74 million, and lower slow motility of 5.17%–11.75%. Additionally, winter had greater normal morphology of 1.30% than both fall and summer. Spring also had greater total motile sperm count of 4.34–4.38 million compared with fall and summer and greater normal morphology of 0.88% than summer. Summer had lower slow motility of 5.05% than fall. Conclusion: This meta‐analysis showed seasonal variations in semen parameters, with generally better semen quality in winter and spring compared with summer and fall. Specifically, these seasons were associated with higher sperm concentration, greater total sperm count, and reduced slow motility compared with summer and fall.
- Open Access
- 25 November 2025
- Published by Academic World Research in Medical Journal of the Islamic Republic Of Iran
- Vol. 39, 156
Global Research Landscape of Artificial Intelligence in Urology: A Systematic Analysis of Emerging Trends, Clinical Impact, and Collaborative Networks (1971–2024)
Despite the rapid integration of artificial intelligence (AI) in urological practice, a comprehensive understanding of research evolution and impact patterns remains unexplored. This analysis provides a systematic examination of its scientific development and future potential. We conducted a comprehensive analysis of AI-related urological publications through October 2024 using the Scopus database. The study incorporated English-language original articles and reviews, utilizing VOSviewer, GraphPad Prism, and Data Wrapper for analysis and visualization. Our investigation encompassed 5755 publications, comprising 5109 original articles and 646 reviews, with 63.9% being open access. The field demonstrated exponential growth from a single publication in 1971 to 1337 publications in 2024, garnering 112,583 citations. The past decade has witnessed the emergence of the most influential articles, particularly those focusing on deep learning (DL) applications in urological cancer detection. The USA-led global contributions (31.1%), followed by China (23.7%) and India (8.2%). "Scientific Reports" emerged as the leading journal with 171 publications. Titles and abstracts analysis revealed key focuses on DL in imaging (n = 1067), chronic kidney disease (n = 801), and advanced DL methodologies (n = 794). The keyword analysis identified "machine learning" as the dominant theme (1331 occurrences), with "prostate cancer" (955) and "deep learning" (838) following closely. Contemporary trends show significant shifts toward ChatGPT applications, pharmacovigilance, and AI-assisted surgical planning. In terms of international collaboration, the USA demonstrated the strongest network with a link strength of 1543. This study traces AI's evolution in urology, from basic ML to advanced clinical tools, with particular advancement in radiomics, imaging, and biomarker analysis. Successful future implementation necessitates addressing ethical considerations, technical hurdles, and practical challenges while maintaining focus on patient safety and equitable healthcare access.
- 25 November 2025
- Published by Academic World Research in Medical Journal of the Islamic Republic Of Iran
- Vol. 39, 156
Open AccessGlobal Research Landscape of Artificial Intelligence in Urology: A Systematic Analysis of Emerging Trends, Clinical Impact, and Collaborative Networks (1971–2024)
Despite the rapid integration of artificial intelligence (AI) in urological practice, a comprehensive understanding of research evolution and impact patterns remains unexplored. This analysis provides a systematic examination of its scientific development and future potential. We conducted a comprehensive analysis of AI-related urological publications through October 2024 using the Scopus database. The study incorporated English-language original articles and reviews, utilizing VOSviewer, GraphPad Prism, and Data Wrapper for analysis and visualization. Our investigation encompassed 5755 publications, comprising 5109 original articles and 646 reviews, with 63.9% being open access. The field demonstrated exponential growth from a single publication in 1971 to 1337 publications in 2024, garnering 112,583 citations. The past decade has witnessed the emergence of the most influential articles, particularly those focusing on deep learning (DL) applications in urological cancer detection. The USA-led global contributions (31.1%), followed by China (23.7%) and India (8.2%). "Scientific Reports" emerged as the leading journal with 171 publications. Titles and abstracts analysis revealed key focuses on DL in imaging (n = 1067), chronic kidney disease (n = 801), and advanced DL methodologies (n = 794). The keyword analysis identified "machine learning" as the dominant theme (1331 occurrences), with "prostate cancer" (955) and "deep learning" (838) following closely. Contemporary trends show significant shifts toward ChatGPT applications, pharmacovigilance, and AI-assisted surgical planning. In terms of international collaboration, the USA demonstrated the strongest network with a link strength of 1543. This study traces AI's evolution in urology, from basic ML to advanced clinical tools, with particular advancement in radiomics, imaging, and biomarker analysis. Successful future implementation necessitates addressing ethical considerations, technical hurdles, and practical challenges while maintaining focus on patient safety and equitable healthcare access.
- 7 May 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 37 (12) , 950-964
Racial/Ethnic differences in male reproductive health: a systematic review and meta-analysis of semen parameters and hormonal profiles in the United States
We conducted systematic review and meta-analysis of differences in semen parameters and reproductive hormones between White, Black, Asian, Hispanic, and non-Hispanic men in the United States. We systematically searched PubMed, Scopus, and Web of Science. Of 2624 studies identified, 25 studies were included for meta-analysis. The pooled analysis revealed that White men compared to Black men had higher sperm concentration of +26.43 million/ml (95%CI = 7.81, 45.05; I2 = 98.98%), higher total sperm count of +128.35 million (95%CI = 82.10, 174.60; I2 = 98.46%), lower age-adjusted free testosterone of −15.12 pmol/L (95%CI = −29.89, −0.35; I2 = 99.55%), lower age-adjusted estradiol of −15.23 pmol/L (95%CI = −27.61, −2.85; I2 = 99.96%), and lower age-adjusted SHBG of −1.52 nmol/L (95%CI = −2.60, −0.44; I2 = 95.65%). Compared to Asian men, White men had higher age-adjusted estradiol of +0.97 pmol/L (95%CI = 0.81, 1.14; I2 = 0%) and Black men had higher SHBG of +2.93 nmol/L (95%CI = 2.63, 3.23; I2 = 0%). Hispanic compared to non-Hispanic men had higher sperm concentration of +5.12 million/ml (95%CI = 4.17, 6.06; I2 = 60.67%) and higher total motility of +5.28% (95%CI = 0.49, 10.07; I2 = 93.11%), lower age-adjusted total testosterone of −0.77 nmol/L (95%CI = −1.22, −0.33; I2 = 98.51%), lower age-adjusted estradiol of −12.54 pmol/L (95%CI = −23.26, −1.81; I2 = 99.82%), and lower age-adjusted SHBG of −2.08 nmol/L (95%CI = −4.13, −0.02; I2 = 99.57%). In conclusion, this meta-analysis found ethnic variations in male reproductive parameters in the United States.
- 7 May 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 37 (12) , 950-964
Racial/Ethnic differences in male reproductive health: a systematic review and meta-analysis of semen parameters and hormonal profiles in the United States
We conducted systematic review and meta-analysis of differences in semen parameters and reproductive hormones between White, Black, Asian, Hispanic, and non-Hispanic men in the United States. We systematically searched PubMed, Scopus, and Web of Science. Of 2624 studies identified, 25 studies were included for meta-analysis. The pooled analysis revealed that White men compared to Black men had higher sperm concentration of +26.43 million/ml (95%CI = 7.81, 45.05; I2 = 98.98%), higher total sperm count of +128.35 million (95%CI = 82.10, 174.60; I2 = 98.46%), lower age-adjusted free testosterone of −15.12 pmol/L (95%CI = −29.89, −0.35; I2 = 99.55%), lower age-adjusted estradiol of −15.23 pmol/L (95%CI = −27.61, −2.85; I2 = 99.96%), and lower age-adjusted SHBG of −1.52 nmol/L (95%CI = −2.60, −0.44; I2 = 95.65%). Compared to Asian men, White men had higher age-adjusted estradiol of +0.97 pmol/L (95%CI = 0.81, 1.14; I2 = 0%) and Black men had higher SHBG of +2.93 nmol/L (95%CI = 2.63, 3.23; I2 = 0%). Hispanic compared to non-Hispanic men had higher sperm concentration of +5.12 million/ml (95%CI = 4.17, 6.06; I2 = 60.67%) and higher total motility of +5.28% (95%CI = 0.49, 10.07; I2 = 93.11%), lower age-adjusted total testosterone of −0.77 nmol/L (95%CI = −1.22, −0.33; I2 = 98.51%), lower age-adjusted estradiol of −12.54 pmol/L (95%CI = −23.26, −1.81; I2 = 99.82%), and lower age-adjusted SHBG of −2.08 nmol/L (95%CI = −4.13, −0.02; I2 = 99.57%). In conclusion, this meta-analysis found ethnic variations in male reproductive parameters in the United States.
- 10 March 2025
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 24 (1) , 78
Mapping the landscape of vitamin D in cancer studies: a systematic global investigation
Purpose This comprehensive study examines the multifaceted relationship between vitamin D and cancer, synthesizing key scientific advancements and global research trends to guide future investigations and address critical gaps in the field. Methods Publications on vitamin D and cancer were retrieved from Scopus up to November 2024. English-language original and review articles were analyzed using Excel, VOSviewer, and Scimago Graphica, focusing on publication trends, citation impacts, and research themes. Results A total of 11,442 publications (80.01% original articles, 19.98% reviews; 51.24% open access) were analyzed. The United States of America led in publications (38.3%) and citations (56.2%), followed by China (7.7%) and the United Kingdom (7.2%) in output, and the United Kingdom (10.6%) and Germany (6.4%) in citations. Countries with the highest citations per document were Belgium (103.4), Slovenia (87.9), and Puerto Rico (76.6). The most frequently studied cancers in relation to vitamin D were breast, colorectal, prostate, skin, lung, ovarian, pancreatic, gastric, hepatocellular, thyroid, leukemia, multiple myeloma, bladder, lymphoma, osteosarcoma, cervical, endometrial, and glioblastoma, respectively. Cluster analysis revealed key patterns related to vitamin D: Calcitriol’s chemopreventive role in breast, prostate, and colorectal cancers, dietary vitamin D for its involvement in ovarian cancer, vitamin D for regulation of cancer-related hypercalcemia, vitamin D deficiency links to inflammation-obesity-cancer risk, VDR polymorphisms affecting outcomes in lung and colorectal cancers, and vitamin D’s photoprotective effects on skin malignancies, and vitamin D in ulcerative colitis-related cancer. The most cited articles emphasized optimal vitamin D levels and cancer prevention. Conclusion This study highlights the extensive research on vitamin D and its complex links to cancer, emphasizing future prospects with a focus on precision medicine approaches, including targeted supplementation and genomic analyses, to better address individual variability in cancer prevention and treatment.
- 10 March 2025
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 24 (1) , 78
Mapping the landscape of vitamin D in cancer studies: a systematic global investigation
Purpose This comprehensive study examines the multifaceted relationship between vitamin D and cancer, synthesizing key scientific advancements and global research trends to guide future investigations and address critical gaps in the field. Methods Publications on vitamin D and cancer were retrieved from Scopus up to November 2024. English-language original and review articles were analyzed using Excel, VOSviewer, and Scimago Graphica, focusing on publication trends, citation impacts, and research themes. Results A total of 11,442 publications (80.01% original articles, 19.98% reviews; 51.24% open access) were analyzed. The United States of America led in publications (38.3%) and citations (56.2%), followed by China (7.7%) and the United Kingdom (7.2%) in output, and the United Kingdom (10.6%) and Germany (6.4%) in citations. Countries with the highest citations per document were Belgium (103.4), Slovenia (87.9), and Puerto Rico (76.6). The most frequently studied cancers in relation to vitamin D were breast, colorectal, prostate, skin, lung, ovarian, pancreatic, gastric, hepatocellular, thyroid, leukemia, multiple myeloma, bladder, lymphoma, osteosarcoma, cervical, endometrial, and glioblastoma, respectively. Cluster analysis revealed key patterns related to vitamin D: Calcitriol’s chemopreventive role in breast, prostate, and colorectal cancers, dietary vitamin D for its involvement in ovarian cancer, vitamin D for regulation of cancer-related hypercalcemia, vitamin D deficiency links to inflammation-obesity-cancer risk, VDR polymorphisms affecting outcomes in lung and colorectal cancers, and vitamin D’s photoprotective effects on skin malignancies, and vitamin D in ulcerative colitis-related cancer. The most cited articles emphasized optimal vitamin D levels and cancer prevention. Conclusion This study highlights the extensive research on vitamin D and its complex links to cancer, emphasizing future prospects with a focus on precision medicine approaches, including targeted supplementation and genomic analyses, to better address individual variability in cancer prevention and treatment.